Clinical trial
Multicenter Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections
NCT03162458 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections
- Lead sponsor
- Materia Medica Holding
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 22, 2015
- Completion date
- April 29, 2015
- Enrollment
- 142 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
acute upper respiratory infections